Is BBH a buy? - Seeking Alpha

Quote & Headlines Market Currents StockTalk

Today 5d 1m 3m 1y 5y 10y

52wk high:

52wk low:

EPS:

PE:

Div Rate:

Yield:

Market Cap:

Volume:

337 people get BBH articles and Market Currents by email alert.

Get email alerts on BBH »

HEADLINES:

A Journey To Add Biotech To The Portfolio
Gregory Stuckey • Sat, May 18 • 9 Comments
Playing To The Strengths Of Biotech
Richard Cox • Sat, Apr 13 • 6 Comments
Under The Hood: An Unheralded Biotech ETF
Benzinga • Thu, Apr 11 • 1 Comment
Gilead Sciences: Stribild Recommended, Great Long-Term Hold
Nick Chiu • Tue, Mar 26 • 3 Comments
3 Stocks With Positive Upgrades And How To Invest
Nick Chiu • Thu, Feb 28
2 High-Alpha ETFs For 2013
Macro Investor • Fri, Jan 11 • 2 Comments
Follow The Dogs Of The World: ETF Laggards To Consider In 2013
Carl T. Delfeld • Thu, Jan 3
More M&A Deals Could Boost Biotech ETFs
Tom Lydon • Thu, Dec 13, 2012
2 ETF Sectors That Are Profiting From Individual Stock Trends
Gary Gordon • Tue, Dec 11, 2012 • 1 Comment
Best And Worst ETFs And Mutual Funds: Healthcare Sector
David Trainer • Wed, Oct 24, 2012 • 5 Comments
What's The Diagnosis For These 4 Biotechnology ETFs?
Henry Swann • Tue, Oct 16, 2012 • 1 Comment
2 Roaring Sectors: Are They Still A Buy?
BubbleBustInvesting • Mon, Sep 10, 2012 • 2 Comments
An Incredibly Boring Investment Strategy That Works
Kurtis Hemmerling • Thu, Sep 6, 2012 • 30 Comments
Biotech ETFs Cool After Strong Run
Tom Lydon • Tue, Aug 14, 2012
The 5 Best Performing ETFs In 2012 So Far
Zacks Investment Research • Tue, Jul 24, 2012
Biotech Disaster 101: When The Market Takes A Dive, Biotechs Sink To The Bottom
Spencer Knight • Wed, Jun 6, 2012 • 1 Comment
Is The Market In Trouble?
George Simone • Tue, May 22, 2012 • 9 Comments
Top 5 Biotech ETFs
David Fry • Tue, May 15, 2012 • 5 Comments
Exciting Innovations In Nanotechnology On The Edge Of Coming To Commercial Markets
Robert Hallberg • Thu, Apr 26, 2012
Choosing The Right Biotech ETF Exposure
Tom Lydon • Mon, Apr 23, 2012 • 1 Comment

To learn more about Seeking Alpha Pro, click here.

Under The Hood: An Unheralded Biotech ETF
Benzinga • Thu, Apr 11 • 1 Comment
Future Innovation Is Undervalued
Wall St. Cheat Sheet • Mon, Oct 25, 2010 • 5 Comments
5 Facts You Should Know About HOLDRS
Michael Johnston • Wed, Mar 10, 2010 • 1 Comment
Re-Evaluating Your Healthcare Exposure: A Sector ETF Overview
Morningstar • Thu, Mar 4, 2010
Time for Biotech To Turn Around?
Bill Luby • Thu, May 1, 2008 • 3 Comments

A Journey To Add Biotech To The Portfolio
Gregory Stuckey • Sat, May 18 • 9 Comments
Playing To The Strengths Of Biotech
Richard Cox • Sat, Apr 13 • 6 Comments
Gilead Sciences: Stribild Recommended, Great Long-Term Hold
Nick Chiu • Tue, Mar 26 • 3 Comments
3 Stocks With Positive Upgrades And How To Invest
Nick Chiu • Thu, Feb 28
2 High-Alpha ETFs For 2013
Macro Investor • Fri, Jan 11 • 2 Comments
Follow The Dogs Of The World: ETF Laggards To Consider In 2013
Carl T. Delfeld • Thu, Jan 3
More M&A Deals Could Boost Biotech ETFs
Tom Lydon • Thu, Dec 13, 2012
2 ETF Sectors That Are Profiting From Individual Stock Trends
Gary Gordon • Tue, Dec 11, 2012 • 1 Comment
Best And Worst ETFs And Mutual Funds: Healthcare Sector
David Trainer • Wed, Oct 24, 2012 • 5 Comments
What's The Diagnosis For These 4 Biotechnology ETFs?
Henry Swann • Tue, Oct 16, 2012 • 1 Comment
2 Roaring Sectors: Are They Still A Buy?
BubbleBustInvesting • Mon, Sep 10, 2012 • 2 Comments
An Incredibly Boring Investment Strategy That Works
Kurtis Hemmerling • Thu, Sep 6, 2012 • 30 Comments
Biotech ETFs Cool After Strong Run
Tom Lydon • Tue, Aug 14, 2012
The 5 Best Performing ETFs In 2012 So Far
Zacks Investment Research • Tue, Jul 24, 2012
Biotech Disaster 101: When The Market Takes A Dive, Biotechs Sink To The Bottom
Spencer Knight • Wed, Jun 6, 2012 • 1 Comment
Is The Market In Trouble?
George Simone • Tue, May 22, 2012 • 9 Comments
Top 5 Biotech ETFs
David Fry • Tue, May 15, 2012 • 5 Comments
Exciting Innovations In Nanotechnology On The Edge Of Coming To Commercial Markets
Robert Hallberg • Thu, Apr 26, 2012
Choosing The Right Biotech ETF Exposure
Tom Lydon • Mon, Apr 23, 2012 • 1 Comment
ETF Stats For January 2012: Trading Activity Continues To Slow
Ron Rowland • Tue, Feb 7, 2012

There are no Transcripts on BBH.

2012 biotech medal winners ... so far

at MarketWatch.com (Aug 1, 2012)
Chuck Jaffe: ETFs claim another fund industry victim

at MarketWatch.com (Aug 28, 2011)

BBH vs. ETF Alternatives

BBH Description

The Market Vectors® Biotech ETF (BBH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the Market Vectors US Listed Biotech 25 Index (MVBBHTR). The Index is a rules-based index intended to track the overall performance of 25 of the largest U.S. listed, publicly traded biotech companies.
See more details on sponsor's website

Sector: Healthcare

Country: United States

Key Info

In Your Portfolio: A Guide to Sector ETFs, A Guide to Healthcare, Pharma and Biotech ETFs
Asset Class Performance: Sectors

All
| Earnings
| Dividends
| M&A
| On the move

Thursday, May 16, 1:49 PM Biotech names are weak today on the back of several ASCO data presentation releases: REGN -2.3%, ALXN -4.2%, VRTX -2.3%, CELG -4.5%, ARRY -2.2%, AMGN -1.4%. 1 Comment [Healthcare, On the Move]
Thursday, March 28, 4:24 PM Biotech ETFs close at or near all-time highs as heavyweights Amgen (AMGN +2.4%), Biogen (BIIB +5.2%), Celgene (CELG +2.4%) and Gilead Sciences (GILD +2.5%) make new 52-week highs going into the holiday weekend. 1 Comment [Healthcare]
Monday, May 14, 2012, 11:45 AM Biotech ETFs are near all-time highs despite overall market weakness, due to successful trials - e.g. for Vertex's (VRTX) cystic fibrosis treatment - and because some investors are betting on deals occurring. One ETF that is doing particularly well this year is iShares Nasdaq Biotech (IBB). Others include XBI, FBT and BBH. 6 Comments [Healthcare]
Monday, March 12, 2012, 12:07 PM Shares of Anthera Pharmaceuticals (ANTH -52.1%) can't stop the freefall that was triggered by Friday's announcement that it's canceling its late-stage trial of its experimental treatment for heart disease. Adam Feuerstein eyes the recent carnage with a number of biotech names to conclude that "fail" is now re-entering the lexicon of investors in the sector. Comment! [On the Move, Healthcare, Quick Ideas]
Wednesday, September 7, 2011, 11:36 AM The biotech industry looks ripe for more gains after posting a second consecutive year of profits and seeing M&A activity heat up, says Karvy Global Services. Crunching the numbers reveals 8 stocks with implied upside potential based on quarterly results and analyst recommendations. Picks: HITK, CELG, DNDN, WX, TEVA, ILMN, CRL, BIIB. Comment! [Quick Ideas]
Thursday, August 4, 2011, 4:05 PM Dendreon (DNDN -67.4%) takes down an entire industry, with the Amex Biotech index falling an astonishing 10.4%. "Biotech risk takers burned on this one might be less risk tolerant going forward," one analyst explains. "The biotech group does work like that, especially for product failures." IBB -7.9%. XBI -9.8%. Comment! [Healthcare, On the Move, Top Stories]
Monday, June 27, 2011, 11:28 AM Biofuels developer Verenium (VRNM +8%) announces it has entered into a collaboration with Novus International to develop new enzymes for the animal health and nutrition markets. Comment! [Energy, Healthcare, On the Move]
Monday, June 27, 2011, 11:11 AM XOMA soars 33% after announcing the discovery of two new classes of fully human monoclonal antibodies at the American Diabetes Association 71st Scientific Sessions in San Diego. Comment! [Healthcare, On the Move]
Thursday, June 23, 2011, 4:17 PM Repligen's (RGEN +5%) jumps after its spinal muscular atrophy drug gets a fast-track designation from the FDA, and a postive opinion for orphan status from the European Medicines Agency. Comment! [Healthcare]
Wednesday, June 22, 2011, 9:52 AM Achillion Pharmaceuticals (ACHN +11.5%) jumps after pricing its secondary offering at $5.90, a 1.8% discount to yesterday's close. The company plans to use the $52M it raised to bring its new line of hepatitis-c drugs to market. Comment! [Healthcare, On the Move]
Monday, June 20, 2011, 4:20 PM Biogen-IDEC (BIIB +4.1%) closes at the top of the S&P leader board after ISI Group ups it to Buy, citing a strong pipeline, and noting its new BG-12 multiple-sclerosis pill can double earnings over the next three to four years. Comment! [Healthcare, On the Move]
Friday, June 17, 2011, 8:51 AM Vivus (VVUS) reports positive results for phase III testing of its erectile dysfunction drug Avanafil. The study is the last in a series to evaluate the drug's safety and efficacy in treating ED in patients who have undergone a radical prostatectomy. Shares +4% premarket. Comment! [Healthcare, On the Move]
Monday, March 7, 2011, 7:43 AM Sanofi (SNY) extends its offer for the outstanding shares of Genzyme (GENZ) to April 1 from March 16. Meanwhile, other biotech firms focused on rare diseases say the Sanofi-Genzyme deal puts many peers into play as takeover targets. Comment!
Saturday, October 30, 2010, 4:58 PM In a major policy reversal, the DoJ filed an amicus brief late yesterday saying human DNA and other genes shouldn't be eligible for patents. It's unclear whether the Patent Office will adopt the position, which could potentially force some biotech firms to change the way they develop drugs.
Comment!
Monday, February 22, 2010, 3:14 PM Sector ETF strength: Regional Banks– RKH +2.3%. Commercial Banks– KBE +2.3%. Financials– XLF +1.5%. Coal– KOL +1%. Transports– IYT +1%.
Sector ETF weakness: Solar– KWT -1.6%. Biotech– BBH -1.2%. Energy– XLE -1.1%. Agriculture– DBA -0.9%. Comment!
Monday, February 22, 2010, 10:10 AM Sector ETF strength: Regional Banks– RKH +1.3%. Commercial Banks– KBE +1.3%. Heating Oil– UHN +1.1%.
Sector ETF weakness: Solar– KWT -1.8%. Solar– TAN -1.4%. Base Metals– DBB -1%. Biotech– BBH -1%. Comment!

Dr. Kris
Bear alert! Several industry group etfs showing signs of overextension: Timber $CUT, Biotech ($FBT, $BBH, $IBB), Pharma ($PJP)...
Mar 5, 1:55 PM
Reply (2)

• !Report Abuse
View all 2 replies
Dr. Kris: If you're in any of these, you might want to start putting in a trailing (mental) stop/loss; lighten up; or protect position.
Mar 5, 1:56 PM
• !Report Abuse
Hillbilly Stock Star: They look like Panda Bears! LoL!
Mar 5, 1:58 PM
• !Report Abuse
Add a reply...

140 characters

Dr. Kris
Biotech looking anemic: After a great run, biotech etfs are stumbling. Breaking support today are $BBH, $IBB, $FBT.
10/31/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Master Che
ABT ADP ALIGN AMZN BAS BBH BIIB CLR CHTR CMG CRZO CSCO CSOD CTBI CVX FB GE HOGS HOMB HPQ HRL INTC LINE KMP http://bit.ly/Nz9iQD
10/11/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Ryan Mallory
14 Stocks That Only Go Up & Up http://bit.ly/SJ796L ABT ALGN ARIA BBH BIIB CTBI DHI EQIX HD HOMB MDVN PCYC SHW TCBI
10/8/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Justin M. Hall
6/8/11 1:10 PM ET: Given the economic risks, Biotech investors appear to be a bit complacent. IBB, BIS and BBH, FBT, XBI
6/8/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Justin M. Hall
6/6/11 7:30 PM ET: Strategies for Pending Biotech Correction = BIS, IBB, BBH, FBT, XBI, XLV = http://seekingalpha.com/a/5v3l
6/6/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Justin M. Hall
5/31/11 2:30 AM ET: Expecting BIOTECH stock sell-off in June. Get exposure: #1 shares of BIS or #2 IBB, BBH, FBT, XBI puts. Rx Investors.com
5/31/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Justin M. Hall
(BBH) (BIS) (IBB) (FBT) (XBI) 5/25/11 9:45 PM ET: BIOTECH industry due to pullback (-10% to -20%) in June. Think: Sell into ASCO.
5/25/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Jim Van Meerten
BBH - 96% Barchart.com technical buy signal - 10 new highs and up 3.62% in the last month-Relative Strength Index 62.56% and climbing
3/26/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Wall St. Cheat Sheet
Is the Time Right to Invest in Biotech? Soros Thinks So http://ow.ly/3aIvU BBH DNDN TEVA
11/16/10
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

LATEST REPLIES

Dr. Kris
Bear alert! Several industry group etfs showing signs of overextension: Timber $CUT, Biotech ($FBT, $BBH, $IBB), Pharma ($PJP)...
Mar 5, 1:55 PM
Reply (2)

• !Report Abuse
View all 2 replies
Dr. Kris: If you're in any of these, you might want to start putting in a trailing (mental) stop/loss; lighten up; or protect position.
Mar 5, 1:56 PM
• !Report Abuse
Hillbilly Stock Star: They look like Panda Bears! LoL!
Mar 5, 1:58 PM
• !Report Abuse
Add a reply...

140 characters

BBH Market Vectors Biotech ETF

BBH

Market Vectors Biotech ETF